Eisenhauer EL - Search Results

1

Understanding and Targeting Apoptotic Pathways in Ovarian Cancer.

Al-Alem LF, Baker AT, Pandya UM, Eisenhauer EL, Rueda BR. Al-Alem LF, et al. Among authors: eisenhauer el. Cancers (Basel). 2019 Oct 24;11(11):1631. doi: 10.3390/cancers11111631. Cancers (Basel). 2019. PMID: 31652965 Free PMC article. Review.

2

Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.

Bercow AS, Eisenhauer EL. Bercow AS, et al. Among authors: eisenhauer el. J Surg Oncol. 2019 Oct;120(5):864-872. doi: 10.1002/jso.25645. Epub 2019 Jul 29. J Surg Oncol. 2019. PMID: 31355450 Review.

3

Minimally invasive interval cytoreductive surgery for advanced ovarian cancer.

Melamed A, Eisenhauer EL. Melamed A, et al. Among authors: eisenhauer el. J Surg Oncol. 2024 Jan;129(1):126-127. doi: 10.1002/jso.27553. Epub 2023 Dec 10. J Surg Oncol. 2024. PMID: 38073159 Review.

4

Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer.

Philp L, Alimena S, Ferris W, Saini A, Bregar AJ, Del Carmen MG, Eisenhauer EL, Growdon WB, Goodman A, Dorney K, Mazina V, Sisodia RC. Philp L, et al. Among authors: eisenhauer el. Gynecol Oncol. 2022 Feb;164(2):421-427. doi: 10.1016/j.ygyno.2021.12.017. Epub 2021 Dec 23. Gynecol Oncol. 2022. PMID: 34953629

5

Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States.

Silberman JN, Bercow AS, Gockley AA, Eisenhauer EL, Sisodia R, Randall T, Del Carmen MG, Goodman A, Castro CM, Melamed A, Bregar AJ. Silberman JN, et al. Among authors: eisenhauer el. Gynecol Oncol. 2023 Aug;175:60-65. doi: 10.1016/j.ygyno.2023.06.001. Epub 2023 Jun 14. Gynecol Oncol. 2023. PMID: 37327540

6

Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.

Rath KS, Loseth D, Muscarella P, Phillips GS, Fowler JM, O'Malley DM, Cohn DE, Copeland LJ, Eisenhauer EL, Salani R. Rath KS, et al. Among authors: eisenhauer el. Gynecol Oncol. 2013 Apr;129(1):103-6. doi: 10.1016/j.ygyno.2013.01.021. Epub 2013 Jan 29. Gynecol Oncol. 2013. PMID: 23369942 Free PMC article.

7

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer.

Eisenhauer EL, Zanagnolo V, Cohn DE, Salani R, O'Malley DM, Sutton G, Callahan MJ, Cobb B, Fowler JM, Copeland LJ. Eisenhauer EL, et al. Gynecol Oncol. 2014 Aug;134(2):262-6. doi: 10.1016/j.ygyno.2014.05.030. Epub 2014 Jun 5. Gynecol Oncol. 2014. PMID: 24910452 Clinical Trial.

8

Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.

Alimena S, Scarpetti L, Blouch EL, Rodgers L, Shannon K, Del Carmen M, Goodman A, Growdon WB, Eisenhauer E, Sisodia RC. Alimena S, et al. Among authors: eisenhauer e. Int J Gynecol Cancer. 2020 Sep;30(9):1397-1403. doi: 10.1136/ijgc-2019-001168. Epub 2020 May 23. Int J Gynecol Cancer. 2020. PMID: 32447294

9

Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 study.

Salani R, O'Malley DM, Copeland LJ, Cohn DE, Backes FJ, Fowler JM, Eisenhauer EL. Salani R, et al. Among authors: eisenhauer el. Int J Gynecol Cancer. 2014 May;24(4):682-6. doi: 10.1097/IGC.0000000000000107. Int J Gynecol Cancer. 2014. PMID: 24651631 Clinical Trial.

10

Ovarian Cancer Surgery - Heed This LION's Roar.

Eisenhauer EL, Chi DS. Eisenhauer EL, et al. N Engl J Med. 2019 Feb 28;380(9):871-873. doi: 10.1056/NEJMe1900044. N Engl J Med. 2019. PMID: 30811915 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page